Voluntis and WellDoc®, two of the industry’s leading digital therapeutics companies, announced today a commercial agreement aimed at combining Voluntis’ insulin titration technology with WellDoc’s extensive digital coaching platform to create a holistic digital diabetes management solution for patients, providers, health systems and health plans.
{iframe}https://www.welldoc.com/images/uploads/2018-WellDoc-Voluntis-PR.pdf{/iframe}